Philips 'recovery subject to consent decree' | HME News
Philips reaches agreement with the U.S. government on a consent decree focusing on the company's defibrillator manufacturing in the U.S. - News | Philips
Philips' respiratory devices recall has even more problems
What's Going On in the Philips CPAP Lawsuits? — Lawsuit Information Center
Philips reaches agreement with the U.S. government on a consent decree focusing on the company's defibrillator manufacturing in the U.S. - News | Philips
Philips agreement with the U.S. government on a consent decree focusing on the company's defibrillator manufacturing in the U.S.
CPAP Recall Lawsuit | April 2023 Update | Settlement Predictions
Not Just Recalls: Philips Tangles With Law Enforcement | MedPage Today
Philips CPAP Recall Leads to Department of Justice Investigation
Device recall and supply chain issues prompt Philips to announce layoffs | Healthcare Finance News
Philips reaches agreement with the U.S. government on a consent decree focusing on the company's defibrillator manufacturing in the U.S. - News | Philips
FDA reaches agreement with automatic external defibrillator maker - UPI.com
DOJ subpoenas Philips over Respironics recall; CEO responds | MDO
Philips Could be Approaching a DOJ Settlement | mddionline.com
Philips Commits to Timeline for Completing Recall| Sleep Review
Will the Philips Recall Ever End? | mddionline.com
After High-Risk Recall And Scathing Inspection Report, Is FDA Warning Letter Next For Philips? :: Medtech Insight
Philips cuts another 6,000 jobs amid 3% sales drop in 2022
US FDA Adds More MDRs To Philips Recall, Including Deaths :: Medtech Insight
FDA lifts injunction on manufacture and distribution of Philips' defibrillators in the US | Sudden Cardiac Arrest Foundation
Concerns About Philips CPAP, Ventilator Replacement Devices
Frustrations Grow Over Philips's Response to CPAP Device Recalls - The New York Times
Consent decree wipes $24M off Philips' first-quarter earnings | Fierce Biotech
Philips Implements Plan To Address FDA Concerns Following Harsh Inspection Report :: Medtech Insight
